PRIMOBOL 100 TABS 25 MG
Primobor 50 Tablets 25 mg
Methenolone Acetate, PhJpn.grade
Molecular Formula: C22H3203 (CAS-434-05-9, ATC-A14AA04)
Molecular Weight: 344.5 gm/mol
Active life: 4-6 hours
Detection time: 4-5 weeks
Anabolic/Androgenic ratio (range): 88:44-57
Primobol®, brand of Methenolone acetate tablets, is an anabolic steroid, a synthetic derivative of testosterone. Each tablet contains 25 mg of Methenolone acetate, PhJpn.grade. It is designated chemically as 17(3-Hydroxy-l-methyl-5a-androst-l-en-3-one acetate.
Nervous system: Increased or decreased libido, headache, anxiety, depression, and generalized paresthesia.
Allergic: Hypersensitivity, including skin manifestations and anaphylactic reactions. Miscellaneous: Inflammation and pain at the site of intramuscular injection.
There have been no reports of acute overdosage with the androgens.
DOSAGE AND ADMINISTRATION:
Aplastic anemia: The therapy may have to be continued for at least 3 months at a dosage of200-300 mg per week.
Osteoporosis: The suggested dosage is 100 mg every 2 weeks, reducing to once every 3 to 4 weeks after an initial response. Progressive breast cancer: 100 mg every 1 to 2 weeks, or 200 mg every 2 to 3 weeks.
Body Building: effectively oral dose: male 50-100 mg per day and female 10-25 mg per day. Each tablet also contains lactose monohydrate, sodium starch glycolate, polyvidone 25,000, microcrystalline cellulose and magnesium stearate as excipients. No colouring agent.
In aplastic anemias of various origins - both the idiopathic forms and those with exogenously damaged bone marrow - high doses of Methenolone acetate may stimulate bone marrow function, particularly erythropoiesis.
INDICATIONS AND USAGE:
1. Aplastic anemias.The therapy may have to be continued for at least
3 months at a dosage of 2-3 mg per kg body weight per day or 4-6 tablets for a person weighing 50 kg.. Since some patients only respond after several months, treatment must not be stopped too soon. After improvement of the clinical picture treatment should, as a general rule, be continued for a further few weeks. Deterioration of the blood count after discontinuation of therapy may be reversed by renewed administration of Primobol
3. Progressive breast cancer